TLP
WST icon

Tri Locum Partners’s West Pharmaceutical WST Stock Holding History

Tri Locum Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,454
Closed -$8.42M – 59
2023
Q3 		$8.42M Sell
22,454
-18,104
-45% -$7M 2.69% 12
2023
Q2 		$15.5M Sell
40,558
-26,272
-39% -$9.39M 5.77% 4
2023
Q1 		$23.2M Sell
66,830
-30,254
-31% -$8.84M 7.05% 2
2022
Q4 		$22.8M Buy
+97,084
New +$23M 9.24% 1

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tri Locum Partners's WST Position: Q4 2023 in Review

Tri Locum Partners sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 22,454 shares — an estimated $8.42M sold.

Tri Locum Partners first reported a position in WST in Q4 2022 and held it in 4 quarters. The position peaked at $23.2M in Q1 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Tri Locum Partners reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Tri Locum Partners sold 22,454 West Pharmaceutical shares in Q4 2023, an estimated $8.42M.
  • Tri Locum Partners first reported a position in West Pharmaceutical in Q4 2022 and held it in 4 quarters.
  • Tri Locum Partners's West Pharmaceutical position peaked at $23.2M in Q1 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Tri Locum Partners's 13F filing for Q4 2023, filed 14 Feb 2024.